Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
29 participants
OBSERVATIONAL
2022-11-10
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
NCT04061135
Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease
NCT01648803
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
NCT01429207
Research on the Brain Mechanism of taVNS in Regulating PD Motor Symptoms
NCT06409338
Movement Disorder Quantification Algorithm Development
NCT01534650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Movement Disorders Patients
Ceraxis product
All patients will have their symptoms evaluated using the Ceraxis product
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ceraxis product
All patients will have their symptoms evaluated using the Ceraxis product
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age greater than or equal to 21 years
* Hoehn and Yahr stage I-III
* Ability to ambulate 200+ meters independently
* Ability to follow 2-step commands
* Clinically responsive to medication or Deep Brain Stimulation (DBS)
* Clinically optimized medication or DBS for at least six months
* Able to tolerate withdrawal of medication and/or DBS
Exclusion Criteria
* Inability to learn how to use the system
* Diagnosis of dementia or impairment that compromises the ability to provide informed consent
* Neurological disease other than Parkinson's disease or essential tremor (i.e. multiple sclerosis, stroke with residual motor deficits)
* Musculoskeletal injury that significantly alters gait
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ceraxis Health, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REDD 0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.